LDLR and coronary artery disorder: It has also been argued that the LDL receptor is more important to CHD risk than APOE4. As observed by Versmissen and colleagues, despite also having two copies of APOE4, patients with loss-of-function mutations in the LDL receptor locus, actually had a lower risk of CHD [145].